OTCPK:ACGI

Stock Analysis Report

Executive Summary

The Amacore Group, Inc. provides and markets healthcare-related membership products for individuals and families.


Snowflake Analysis

Mediocre balance sheet with weak fundamentals.

Share Price & News

How has Amacore Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ACGI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

ACGI

-0.8%

US Healthcare

0.6%

US Market


1 Year Return

-73.5%

ACGI

6.7%

US Healthcare

20.8%

US Market

Return vs Industry: ACGI underperformed the US Healthcare industry which returned 6.7% over the past year.

Return vs Market: ACGI underperformed the US Market which returned 20.8% over the past year.


Shareholder returns

ACGIIndustryMarket
7 Day0%-0.8%0.6%
30 Day-50.0%5.6%2.5%
90 Dayn/a15.3%4.9%
1 Year-73.5%-73.5%8.6%6.7%23.5%20.8%
3 Year0%0%47.0%40.4%46.5%37.0%
5 Year-50.0%-50.0%63.4%52.2%64.6%46.5%

Price Volatility Vs. Market

How volatile is Amacore Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Amacore Group undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Amacore Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Amacore Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ACGI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Amacore Group regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Amacore Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Amacore Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of ACGI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Amacore Group's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Amacore Group performed over the past 5 years?

13.5%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Amacore Group has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Amacore Group's financial position?


In this section we usually analyse Amacore Group's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Amacore Group has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of ACGI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Amacore Group's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Amacore Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.5%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate ACGI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ACGI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ACGI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ACGI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ACGI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Amacore Group's salary, the management and board of directors tenure and is there insider trading?

11.8yrs

Average management tenure


CEO

Amacore Group has no CEO, or we have no data on them.


Management Age and Tenure

11.8yrs

Average Tenure

Experienced Management: ACGI's management team is seasoned and experienced (11.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Management Team

  • Donald Kappauf (72yo)

    Director of Operations and Director of Administration

    • Tenure: 13.4yrs
  • Mark Jarvis (59yo)

    Senior Vice President

    • Tenure: 11.8yrs
  • G. Smith

    Chief Operating Officer and Interim Chief Financial Officer

    • Tenure: 11.3yrs
    • Compensation: US$279.17k

Board Members

  • Shad Stastney (49yo)

    Director

    • Tenure: 11.3yrs
  • Keith Hughes (60yo)

    Director

    • Tenure: 9.8yrs

Company Information

The Amacore Group, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: The Amacore Group, Inc.
  • Ticker: ACGI
  • Exchange: OTCPK
  • Founded: 1993
  • Industry: Managed Health Care
  • Sector: Healthcare
  • Market Cap: US$314.332k
  • Shares outstanding: 1.05b
  • Website: https://null

Location

  • The Amacore Group, Inc.
  • Maitland Promenade 1
  • 485 North Keller Road
  • Maitland
  • Florida
  • 32751
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ACGIOTCPK (Pink Sheets LLC)YesClass A Common StockUSUSDAug 1995

Biography

The Amacore Group, Inc. provides and markets healthcare-related membership products for individuals and families. Its products include limited and major medical insurance programs, supplemental medical ins ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/12/14 00:05
End of Day Share Price2019/12/13 00:00
Earnings2010/06/30
Annual Earnings2009/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.